Neurological Disorder Diagnostics Market Estimated to Record Highest CAGR by 2026 And The Top Players Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation

Neurological disorder diagnostic tools are those used in diagnosis of various neurological disorders. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostics techniques. Imaging techniques such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels and different parts of body, while vitro diagnostic techniques consists of techniques such as biopsy, biomarker, blood test, urine test, and genetic testing.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1867

Market Dynamics

Product launches and approvals of novel neurological diagnostic products is expected to be a major driver for growth of the global neurological disorder diagnostics. For instance, in 2016, Koninklijke Philips N.V. launched its latest Philips IQon Spectral CT in Canada. The latest Philips IQon Spectral CT is the world’s first and only spectral detector CT, designed specifically for spectral imaging. With a new dual-layer spectral detector, the IQon Spectral CT has added spectral resolution to conventional CT scanning. Increasing research and development activities for development of novel diagnosis techniques for neurological disorder is also expected to fuel the market growth. For instance, in 2017, researchers from Assistance Publique – Hôpitaux de Paris (AP-HP) in collaboration with ICM researchers (Inserm/CNRS/UPMC) and Metafora Biosystems, developed a diagnostic blood test for De Vivo disease, a rare neurological illness. Increasing prevalence of neurological disorders is also expected to increase demand for diagnostic devices in the near future.

For instance, According to World Alzheimer Report 2016, around 47 million people are living with dementia worldwide, and this is expected to increase about three-fold to reach 131 million by 2050. Alzheimer is one of the leading causes of dementia and accounts for an estimated 60% to 80% of all of dementia cases, according to 2018 Alzheimer’s Facts and Figures published by Alzheimer’s Association. The global neurological disorder diagnostics market was valued at US$ 10,774.6 Mn in 2017, and is expected to witness a CAGR of 7.3% over the forecast period (2018 – 2026).

Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth

Strategic collaboration among key players in the market is also expected to be another factor fueling growth of the global neurological disorder diagnosis market growth. For instance, in March 2018, Canon Medical Systems, Kumamoto University, and University of Bordeaux entered into collaborative research for development of deep learning technology in magnetic resonance imaging. In 2017, York Instruments Ltd. signed an agreement for three Magnetoencephalography Systems with three leading universities. The University of York, the University of Glasgow in the U.K., and Germany’s University of Konstanz partnered with York Instruments to develop this technology.

Furthermore, North America neurological disorder diagnostics market, and Asia Pacific neurological disorder diagnostics market are expected to show a good growth in the near future due to increasing adoption of diagnostic devices by hospitals and ambulatory care centers in regions. For instance, according to the data published by the Organisation for Economic Co-operation and Development (OECD), in the U.S., the total unit of Magnetic Resonance Imaging (MRI) in hospital and ambulatory care centers in 2015, were around 39.0 per 1,000,000 inhabitants increasing from 31.5 per 1,000,000 population in 2010. In Asia Pacific, Japan is the only country to have over 100 CT scanners per 1,000,000 population. According to Organisation for Economic Co-operation and Development (OECD), Japan had 107.2 CT scanners per 1,000,000 population in 2014.

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1867

Key players operating in the neurological disorder diagnostics market include Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.